Novel Quinic Acid Glycerates from Tussilago farfara Inhibit Polypeptide GalNAc-Transferase.


Journal

Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360

Informations de publication

Date de publication:
04 02 2022
Historique:
revised: 30 11 2021
received: 08 10 2021
pubmed: 2 12 2021
medline: 9 3 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

The discovery of a bioactive inhibitor tool for human polypeptide N-acetylgalactosaminyl transferases (GalNAc-Ts), the initiating enzyme for mucin-type O-glycosylation, remains challenging. In the present study, we identified an array of quinic acid derivatives, including four new glycerates (1-4) from Tussilago farfara, a traditional Chinese medicinal plant, as active inhibitors of GalNAc-T2 using a combined screening approach with a cell-based T2-specific sensor and purified enzyme assay. These inhibitors dose-dependently inhibited human GalNAc-T2 but did not affect O-linked N-acetylglucosamine transferase (OGT), the other type of glycosyltransferase. Importantly, they are not cytotoxic and retain inhibitory activity in cells lacking elongated O-glycans, which are eliminated by the CRISPR/Cas9 gene editing tool. A structure-activity relationship study unveiled a novel quinic acid-caffeic acid conjugate pharmacophore that directs inhibition. Overall, these new natural product inhibitors could serve as a basis for developing an inhibitor tool for GalNAc-T2.

Identifiants

pubmed: 34850523
doi: 10.1002/cbic.202100539
doi:

Substances chimiques

Enzyme Inhibitors 0
Quinic Acid 058C04BGYI
N-Acetylgalactosaminyltransferases EC 2.4.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202100539

Subventions

Organisme : National Natural Science Foundation of China
ID : 31870763
Organisme : Natural Science Foundation of Shandong Province
ID : JQ201721
Organisme : Shanghai Foundation for the Development of Science and Technology
ID : 19JC1413000
Organisme : Research Fund of Medicine and Engineering of Shanghai Jiao Tong University
ID : YG2019QNB27
Organisme : Research Fund of Medicine and Engineering of Shanghai Jiao Tong University
ID : YG2021QN144
Organisme : Department of Biological Sciences, Carnegie Mellon University

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

E. P. Bennett, U. Mandel, H. Clausen, T. A. Gerken, T. A. Fritz, L. A. Tabak, Glycobiology 2011, 22, 736-756.
 
H. J. Joshi, Y. Narimatsu, K. T. Schjoldager, H. L. Tytgat, M. Aebi, H. Clausen, A. Halim, Cell 2018, 172, 632-632, e632;
D. J. Gill, H. Clausen, F. Bard, Trends Cell Biol. 2011, 21, 149-158.
Y. Hu, J. Feng, F. Wu, ChemBioChem 2018, 19, 2503-2521.
 
T.-B. S. Katrine, M. B. Vester-Christensen, E. P. Bennett, S. B. Levery, T. Schwientek, W. Yin, O. Blixt, H. Clausen, J. Biol. Chem. 2010, 285, 36293-36303;
L. Song, C. Bachert, K. T. Schjoldager, H. Clausen, A. D. Linstedt, J. Biol. Chem. 2014, 289, 30556-30566.
 
K. Kato, C. Jeanneau, M. A. Tarp, A. Benet-Pagès, B. Lorenz-Depiereux, E. P. Bennett, U. Mandel, T. M. Strom, H. Clausen, J. Biol. Chem. 2006, 281, 18370-18377;
L. Song, A. D. Linstedt, eLife 2017, 6, e24051.
 
A. Weidemann, G. König, D. Bunke, P. Fischer, J. M. Salbaum, C. L. Masters, K. Beyreuther, Cell 1989, 57, 115-126;
S. Kitazume, Y. Tachida, M. Kato, Y. Yamaguchi, T. Honda, Y. Hashimoto, Y. Wada, T. Saito, N. Iwata, T. Saido, J. Biol. Chem. 2010, 285, 40097-40103.
 
S. A. Khetarpal, K. T. Schjoldager, C. Christoffersen, A. Raghavan, A. C. Edmondson, H. M. Reutter, B. Ahmed, R. Ouazzani, G. M. Peloso, C. Vitali, Cell Metab. 2016, 24, 234-245;
A. G. Holleboom, H. Karlsson, R.-S. Lin, T. M. Beres, J. A. Sierts, D. S. Herman, E. S. Stroes, J. M. Aerts, J. J. Kastelein, M. M. Motazacker, Cell Metab. 2011, 14, 811-818.
A. Mullard, Nat. Rev. Drug Discovery 2021, 20, 251.
US. Food & Drug. Administration, Retrieved from FDA. gov: https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-inherited-form-rickets-x-linked-hypophosphatemia2018.
K. Servick, Science 2021, 372, 1141.
F. Liu, K. Xu, Z. Xu, M. de las Rivas, C. Wang, X. Li, J. Lu, Y. Zhou, I. Delso, P. Merino, R. Hurtado-Guerrero, Y. Zhang, F. Wu, J. Biol. Chem. 2017, 292, 21304-21319.
C. Steentoft, S. Y. Vakhrushev, H. J. Joshi, Y. Kong, M. B. Vester-Christensen, K. T. B. Schjoldager, K. Lavrsen, S. Dabelsteen, N. B. Pedersen, L. Marcos-Silva, EMBO J. 2013, 32, 1478-1488.
E. J. Lee, J. S. Kim, H. P. Kim, J.-H. Lee, S. S. Kang, Food Chem. 2010, 120, 134-139.
J. Chen, S. Mangelinckx, L. Ma, Z. Wang, W. Li, N. De Kimpe, Fitoterapia 2014, 99, 1-6.
X. Zhu, X. Dong, Y. Wang, P. Ju, S. Luo, Helv. Chim. Acta 2005, 88, 339-342.
G. Huet, I. Kim, C. De Bolos, J. Lo-Guidice, O. Moreau, B. Hemon, C. Richet, P. Delannoy, F. Real, P. Degand, J. Cell Sci. 1995, 108, 1275-1285.
Y. Wang, T. Ju, X. Ding, B. Xia, W. Wang, L. Xia, M. He, R. D. Cummings, Proc. Natl. Acad. Sci. USA 2010, 107, 9228-9233.
T. Ju, R. D. Cummings, Proc. Natl. Acad. Sci. USA 2002, 99, 16613-16618.
X.-Q. Song, J.-H. Yu, J. Sun, K.-L. Liu, J.-S. Zhang, H. Zhang, Bioorg. Chem. 2021, 107, 104632.
F. A. Ran, P. D. Hsu, J. Wright, V. Agarwala, D. A. Scott, F. Zhang, Nat. Protoc. 2013, 8, 2281-2308.
M. B. Lazarus, Y. Nam, J. Jiang, P. Sliz, S. Walker, Nature 2011, 469, 564.
 
L. Wang, H. Cai, Y. Hu, F. Liu, S. Huang, Y. Zhou, J. Yu, J. Xu, F. Wu, Cell Death Dis. 2018, 9, 1-17;
Y. Hu, L. Wang, X. Han, Y. Zhou, T. Zhang, L. Wang, T. Hong, W. Zhang, X.-X. Guo, J. Sun, J. Med. Chem. 2018, 62, 1677-1683.
G. Croppi, Y. Zhou, R. Yang, Y. Bian, M. Zhao, Y. Hu, B. H. Ruan, J. Yu, F. Wu, Cell Chem. Biol. 2020, 27, 1483-1499.
Y. Wang, J. Zhu, L. Zhang, J. Med. Chem. 2017, 60, 263-272.
J. L. Dahlin, K. M. Nelson, J. M. Strasser, D. Barsyte-Lovejoy, M. M. Szewczyk, S. Organ, M. Cuellar, G. Singh, J. H. Shrimp, N. Nguyen, Nat. Commun. 2017, 8, 1527.

Auteurs

Juan Feng (J)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China.

Yu-Peng Li (YP)

School of Biological Science and Technology, University of Jinan, Jinan, 250022, China.

Youtian Hu (Y)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China.

Yueyang Zhou (Y)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China.

Hua Zhang (H)

School of Biological Science and Technology, University of Jinan, Jinan, 250022, China.

Fang Wu (F)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH